rs146206159
Variant summary
Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7
The NM_014141.6(CNTNAP2):c.3903G>A(p.Ala1301Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000873 in 1,614,202 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_014141.6 synonymous
Scores
Clinical Significance
Conservation
Publications
- complex neurodevelopmental disorderInheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
- cortical dysplasia-focal epilepsy syndromeInheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Illumina, Labcorp Genetics (formerly Invitae), Orphanet, G2P, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Benign. The variant received -13 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| CNTNAP2 | NM_014141.6 | c.3903G>A | p.Ala1301Ala | synonymous_variant | Exon 24 of 24 | ENST00000361727.8 | NP_054860.1 | |
| LOC105375554 | XR_928094.2 | n.210-20831C>T | intron_variant | Intron 1 of 3 | 
Ensembl
Frequencies
GnomAD3 genomes  0.000158  AC: 24AN: 152224Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.000175  AC: 44AN: 251394 AF XY:  0.000162   show subpopulations 
GnomAD4 exome  AF:  0.0000800  AC: 117AN: 1461860Hom.:  0  Cov.: 32 AF XY:  0.0000743  AC XY: 54AN XY: 727226 show subpopulations 
Age Distribution
GnomAD4 genome  0.000158  AC: 24AN: 152342Hom.:  0  Cov.: 33 AF XY:  0.000188  AC XY: 14AN XY: 74492 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Benign:2 
CNTNAP2: BP4, BP7 -
- -
Cortical dysplasia-focal epilepsy syndrome    Benign:1 
- -
Inborn genetic diseases    Benign:1 
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at